Bruker Daltonics' New ClinProTools 2.1 and flexImaging 2.0 Software Now Permit Integrated Statistical and Image Analysis of Tissue Samples
SEATTLE--(BUSINESS WIRE)--May 28, 2006-- At the 2006 ASMS conference, Bruker Daltonics today announces its new ClinProTools(TM) 2.1 and flexImaging(TM) 2.0 software versions. Together, these integrated software packages allow biologists and clinical researchers to merge statistical analysis on MALDI-TOF profiling spectra with molecular images of tissue distributions of peptide and protein biomarkers. This unique analysis capability is now available on the (...)
Bruker Daltonics Introduces Novel WARP-LC(TM) 1.1 Software for LC/MS/MS Based Quantitative Proteomics; WARP-LC 1.1 Provides Comprehensive Support for All Current Label Chemistries Including ICPL, iTRAQ and ICAT
SEATTLE, May 28, 2006 (BUSINESS WIRE) -- At the 2006 ASMS conference, Bruker Daltonics today announces its novel WARP-LC 1.1 software suite for quantitative proteomics using isotope labeling. WARP-LC is the first comprehensive solution for quantitative LC-MS/MS protein analysis.
All current industry-standard label chemistries are fully supported (ICPL, SILAC, iTRAQ, ICAT, and (18)O/(16)O-C-terminus labeling) and WARP-LC is open to other customized (...)
Bruker Daltonics and Serva Electrophoresis Announce Release of Novel ICPL Triplex Protein Quantitation Technology for Expression Proteomics; Three Independent Entire Proteomes Can Now Be Quantified Simultaneously
SEATTLE, May 28, 2006 (BUSINESS WIRE) -- At the 2006 ASMS conference, Bruker Daltonics Inc. and Serva Electrophoresis GmbH today announce the release of an ICPL(TM) Triplex kit, based on stable isotope labeling technology which has now been further developed by Drs. Friedrich Lottspeich and Josef Kellermann at the Max-Planck-Institute of Biochemistry in Martinsried, Germany.
This novel technology enables true quantitative proteomics of three (...)
Bruker BioSciences Corporation Files Definitive Proxy with the SEC, Including Proposals for Acquisition of Bruker Optics
BILLERICA, Mass.--(BUSINESS WIRE)--May 25, 2006--
Bruker BioSciences Corporation (Nasdaq: BRKR) announced today that it has filed a definitive proxy statement with the Securities and Exchange Commission for its annual meeting of shareholders, which includes proposals relating to shareholder approval of its proposed acquisition of Bruker Optics Inc.
ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR)
Bruker BioSciences Corporation, headquartered in Billerica, (...)
Bruker Daltonics to Host May 30th Press Conference at ASMS Mass Spectrometry Conference in Seattle
BILLERICA, Mass.--(BUSINESS WIRE)--May 23, 2006--
Bruker Daltonics today announced that it will hold a press conference at the American Society for Mass Spectrometry's 54th Annual Conference in Seattle, Washington, at which it plans to announce new mass-spectrometry based products for its pharmaceutical, molecular diagnostics, clinical proteomics and other life-science research customers.
Bruker Daltonics' ASMS press conference will take place on (...)
Bruker Daltonics @ ASMS 2006
May 28 - 31, 2006 -- Bruker Daltonics Hosts Major Events at ASMS 2006 --
At ASMS 2006, Bruker Daltonics will host three Mid-Day Technical Workshops from Monday through Wednesday in Rooms 307 and 308 at the Washington State Convention Center. This is an ideal opportunity to hear in depth technical details in the following application areas while enjoying an ice cream on us! Start time is 12:30 pm each day. Space is limited and will be on a "first come, (...)
Bruker BioSciences Reports Improved First Quarter 2006 Operating Results and Net Income
BILLERICA, Mass.--(BUSINESS WIRE)--May 2, 2006--Bruker BioSciences Corporation (NASDAQ: BRKR) today reported first quarter 2006 revenue of $74.4 million, compared to revenue of $74.9 million in the first quarter of 2005. Excluding the effects of unfavorable foreign currency translation, first quarter 2006 revenue increased by 7% year-over-year.
GAAP net income in the first quarter of 2006 was $0.8 million, or $0.01 per diluted share, compared to GAAP (...)
Bruker BioSciences Corporation to Release First Quarter 2006 Financial Results on May 2, 2006
BILLERICA, Mass.--(BUSINESS WIRE)--April 28, 2006--Bruker BioSciences Corporation (Nasdaq:BRKR) plans to release its first quarter financial results on Tuesday, May 2, 2006 after the market closes. Bruker BioSciences will then host an operator-assisted earnings conference call the following morning, Wednesday, May 3, at 10 a.m. Eastern Time, 7 a.m. Pacific Time. To listen to the webcast, investors can go to www.bruker-biosciences.com and click on the live (...)
Bruker Daltonics Obtains Russian Medical Device Registration for all Flex(TM)-Series MALDI-TOF Mass Spectrometers
BILLERICA, Mass. and MOSCOW--(BUSINESS WIRE)--April 25, 2006--
Bruker Daltonics Inc. today announces that it has obtained registration of its complete MALDI-TOF product line of microflex(TM), autoflex(TM) TOF or TOF/TOF, and ultraflex(TM) TOF/TOF mass spectrometers, as well as of its ClinProRobot(TM) sample preparation platform, as medical devices from the Ministry of Health and Social Development of the Russian Federation.
MALDI-TOF mass spectrometry (...)
Bruker BioSciences Corporation Announces Agreement to Acquire Bruker Optics Inc. for $135 Million in Cash and Stock
BILLERICA, Mass.--(BUSINESS WIRE)--April 17, 2006--
Combined Company Will Be a Leading Provider of Molecular Analysis Solutions to the Life Science, Materials Research, Homeland Security and Industrial Markets
Bruker BioSciences Corporation (NASDAQ: BRKR) today announced that it has entered into a definitive agreement to acquire all of the stock of molecular spectroscopy company Bruker Optics Inc. for $135 million, to be paid approximately 59% in (...)
